Search

Your search keyword '"Roccaro A. M."' showing total 1,084 results

Search Constraints

Start Over You searched for: Author "Roccaro A. M." Remove constraint Author: "Roccaro A. M."
1,084 results on '"Roccaro A. M."'

Search Results

2. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia

3. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis

4. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia

6. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response

7. Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity

8. Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia

9. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88

13. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia

18. Epigenetics in Multiple Myeloma

20. Prognostic role of circulating exosomal miRNAs in multiple myeloma

21. Vascular and Stromal Contributions to Tumor Bone-Homing: Focus on Multiple Myeloma

22. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression

23. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

26. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia

27. Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis

28. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia

29. Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma

31. Data from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment

32. Supplementary Methods from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment

33. Supplementary Figures 1-15, Supplementary Table 1 from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment

34. Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

35. Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

36. Supplementary Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

38. CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation

41. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing

44. Fig S6 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation

45. Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress

46. Supplementary Table 1 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation

47. Supplementary Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress

48. Supplementary Table Legend from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma

50. Supplementary Table from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma

Catalog

Books, media, physical & digital resources